Company Description

AliquantumRx is a biotechnology company advancing Cethromycin, a macrolide antibiotic, for novel therapeutic applications across multiple high-impact disease areas. Our lead indication is dormant liver-stage malaria, where Cethromycin shows strong potential as both a radical cure for Plasmodium vivax and P. ovale and a prophylactic agent against liver-stage P. falciparum infections.